コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ssion of Cxcr4 on B6.SJL-CD45.1 T follicular helper cells.
2 ollicular B cells but a loss in follicular T helper cells.
3 hich is necessary for the proliferation of T helper cells.
4 irs the development of Th17 and T follicular helper cells.
5 lls and indirectly by promoting T follicular helper cells.
6 helper cells and the suppression of type 1 T helper cells.
7 interaction between B cells and T follicular helper cells.
8 tment, which correlated with LN T follicular helper cells.
9 argets pre-germinal B cells and depletes Th2 helper cells.
10 dependent on interactions with T follicular helper cells.
11 e paucity of "Th1," "Th17," and T follicular helper cells.
12 ypically associated with CD4(+) T follicular helper cells.
13 ear a phenotypic resemblance to T follicular helper cells.
14 ters and CD4(+) germinal center T follicular helper cells.
15 T cells into different subsets of effector T helper cells.
16 development that parallel those of CD4(+) T helper cells.
17 led to a profound reduction of T follicular helper cells.
18 also increased the frequency of T follicular helper cells.
19 cterized by proliferation of mature CD4(+) T-helper cells.
20 GCs of lymphoid tissues called follicular T helper cells.
21 exclusively differentiate into T follicular helper cells.
22 xpansion of IFN-gamma-secreting T follicular helper cells.
23 ucosal inflammation driven by Th17 and Th1 T helper cells.
24 features of recently described T peripheral helper cells.
25 o differentiate into CD16(-)/CD25(+)/CD83(+) helper cells.
26 a higher abundance of cytotoxic phenotype T helper cells.
27 ell maturation into CXCR5+PD-1+ T follicular helper cells.
28 levels in part by inhibition of T follicular helper cells.
29 dent cross-activation of myeloid cells and T helper cells.
30 nv (gp120TM) proteins and propagated in Vero helper cells.
31 nes involved in the polarization of CD4(+) T helper cells.
32 ves them unable to regulate CD4 T follicular helper cells.
33 xon-specific T cells, predominantly of the T-helper cell 1 (Th1) phenotype, in 30 patients with AdV d
34 pha receptor constant chain and changes in T helper cell 1, T helper cell 2, T helper cell 17, CD8+ e
36 nces of inhibiting components of the IL-23/T-helper cell 17 pathway-the target of next-generation bio
37 anges in T helper cell 1, T helper cell 2, T helper cell 17, CD8+ effector, CD4+ memory, and regulato
38 models, dry eye disease is associated with T helper cell 17-mediated inflammation of the ocular surfa
41 rmatitis-like disease that is dependent on T helper cell 2 cytokines and is associated with high seru
43 tant chain and changes in T helper cell 1, T helper cell 2, T helper cell 17, CD8+ effector, CD4+ mem
46 anies atherosclerosis, autoreactive CD4(+) T-helper cells accumulate in the atherosclerotic plaque.
47 mune checkpoint therapy induces T follicular helper cell activation of B cells to facilitate the anti
51 ay be related to development of T follicular helper cells and antiviral inflammatory sequelae derived
53 rophages, and efficiently activated CD4(+) T-helper cells and CD8(+) cytotoxic T lymphocyte cells.
54 ncreased proportions of cytotoxic follicular helper cells and cytotoxic T helper (T(H)) cells (CD4-CT
55 sed DC antigen-presenting cell function to T helper cells and DC calcium mobilization and chemotaxis
58 differentiation and function of T follicular helper cells and germinal center B cells, the two main p
59 D025 had decreased frequency of T follicular helper cells and increased frequency of T follicular reg
60 TT-specific, CD40 ligand-expressing CD4(+) T helper cells and maturation of antigen-presenting cells.
61 omparison of TCRs from conventional memory T helper cells and mTregs isolated from skin revealed litt
63 lisation assays and circulating follicular T-helper cells and plasmablast cells were measured in seru
65 required for the development of T follicular helper cells and T follicular regulatory (Tfr) cells tha
66 g the reduced expansion of both T follicular helper cells and Th17 cells and a compensatory increase
68 e upregulation of type 2 anti-inflammatory T helper cells and the suppression of type 1 T helper cell
69 duced expression of FcgammaRIIIa on CD4(+) T helper cells and their ability to co-stimulate T-cell ac
70 ween the frequency of tonsillar T follicular helper cells and tonsillar Ag-specific Ab-secreting cell
72 ior to treatment suggested that T follicular helper cells and various other immune cell subsets may p
73 dendritic cells (which activate T follicular helper cells) and lymphatic sinus-associated SIGNR1(+) m
74 man germinal-centre B cells and T follicular helper cells, and antagonized the induction of phosphory
75 GS did abrogate germinal center T follicular helper cells, and blunted PE-specific germinal center B
76 ce have severely decreased GCs, T follicular helper cells, and high-affinity Abs after immunization w
77 iated by DNA threads released by activated T helper cells, and identify a potential therapeutic targe
78 pitopes that elicit CD8(+) T cells, CD4(+) T helper cells, and IgG2b antibodies, and (ii) adjuvant ac
79 r T cell populations, including T follicular helper cells, and increases germinal center B cells and
84 tion, PI3K in B lymphocytes, iCOS-iCOSL in T helper cells, and the role of NFAT in regulating the imm
85 s comprised both memory Th1 and T follicular helper cells, and were rapidly expanded and activated af
90 cells, suggesting that the dual costimulated helper cells are themselves helped by a CD134(+) cell(s)
91 which are composed of about 65% T follicular helper cells as defined by the expression of the cell su
92 ponse was predominantly mediated by type-1 T helper cells, as demonstrated by the profiling of the Ig
93 e central memory T cells and of T follicular helper cells associated with specific antibody responses
94 he IL-23R(-/-)MRL.lpr had fewer T follicular helper cells, B cells, and plasma cells, leading to decr
95 novel endotyping approach purely based on T helper cell biomarkers has been developed and has shown
96 d with an increase in proliferating CD4(+) T-helper cells but not with an increase in T-regulatory ce
97 we show that these CD4(+)CD44(hi)CD62L(lo) T helper cells by gene expression are a distinct T-cell po
99 sed splenic CD3+ T cells, specifically CD4+T helper cells, compared to splenocytes from non-irradiate
100 uced a partial expansion of the T follicular helper cell compartment, essential for B cell memory res
102 es abundance was predictive of higher host T-helper cell counts, suggesting an important link between
104 ng in the generation of high levels of CD4 T-helper cell cytokines or increased migration of cytolyti
105 mmunity in fish, through downregulation of T-helper cell cytokines, antigen presentation machinery, a
106 s, which is associated with an increase in T-helper cells, cytotoxic T cells, T-cell functional respo
108 at IFN-gamma secreted by pre-existing memory helper cells determines both isotype and specificity of
109 Long noncoding RNAs play a pivotal role in T-helper cell development but little is known about their
113 und that activation of glycolysis supports T helper cell differentiation by controlling acetyl-coA an
114 the mechanisms by which cytokines regulate T helper cell differentiation decisions is increasingly im
116 factor-dependent T follicular regulatory and helper cell differentiation in the Peyer's patches.
126 cell epitopes, impedes the presentation of T helper cell epitopes, and attracts mannose binding prote
127 germinal center formation, and T follicular helper cells, especially when the load of the antigen is
128 te their p27 protein levels, and propose a T helper cell exhaustion model resembling that of stem cel
131 promoted the differentiation of T follicular helper cells followed by an enhanced germinal center res
132 increase in T cell activation and follicular helper cells for the following months; and a progressive
133 d that the preservation of CXCR5(+) CD4(+) T helper cell frequencies and activation status of B cells
135 enic germinal center B-cell and T-follicular helper cell frequencies that collaborate to produce anti
138 has been associated with a loss of CD4(+) T helper cell function and with the accumulation of anergi
142 ling-selective variants reduced T follicular helper cells, germinal center formation, immunoglobulin,
144 Additionally, gp130-deficient T follicular helper cells had lower expression of Maf, IL-21, and ICO
145 oduced mainly by Th17 cells and T follicular helper cells, has been intensively investigated in B cel
147 uction, and nomenclature parallel those of T helper cells, ILCs do not require adaptive immune progra
148 ction on the development of their adaptive T helper cell immune response has not been addressed.
149 ed signaling to the promotion of effective T helper cell immune responses, during both anti-fungal ho
152 o A. muciniphila are limited to T follicular helper cells in a gnotobiotic setting, without appreciab
153 ly expand alloreactive IL-18R1+ T peripheral helper cells in allograft tissues to promote donor-speci
154 olific innate killers, NK cells are also key helper cells in antiviral defense, influencing adaptive
156 vidence concerning the roles of T follicular helper cells in regulating pathogenic GC and autoreactiv
158 creased numbers of T-lymphocytic cells and T-helper cells in the junctional epithelium of SPF mice co
159 accumulation of CXCR3(+)CD4(+) T follicular helper cells in the spleen and enhanced Ab responses to
161 fferences between TPH cells and T follicular helper cells, including altered expression of BCL6 and B
162 nscriptional characteristics of follicular T helper cells increasingly shaped the circulating HCV-spe
163 center (GC) reaction, in which T follicular helper cells interact with GC B cells to produce antibod
164 ated that reduction of Pparg expression in T-helper cells is critical for spontaneous SLE-like autoim
166 analysis showed upregulation of T follicular helper cell markers, most notably CXCR5 and its ligand C
172 lper type 1 differentiation and T-follicular-helper cell polarization and increased the abundance of
173 the effect of increased STAT1 activity on T helper cell polarization and to investigate the therapeu
175 IL-1 induced IL-22 production from a mixed T helper cell population comprised of Th1, Th17, and Th22
176 ell functions and influence the T follicular helper-cell population; this active role of B cells coul
177 pecific transcription factors for distinct T-helper cell populations, we focus on signal transducer a
181 ) mouse leads to a shift of the follicular T helper cell program from follicular T helper (Tfh)-IL-17
182 d DCs, coupled with greater CD4 T follicular helper cells, prolonged B cell activation, autoantibody
184 l subsets designated peripheral T follicular helper cells (pTfh cells) and non-pTfh cells to assess H
185 te acquisition of the virus because CD4(+) T helper cells, required for an effective immune response,
187 e demonstrate that the CoV-2-specific CD4+ T helper cell response is directed against all 3 proteins
188 ge malaria and interfere with conventional T helper cell responses and follicular T helper (TFH)-B ce
193 S. Typhi porins programs type I T follicular helper cell responses that contribute to the diversifica
194 us, C. albicans morphology drives distinct T helper cell responses that provide tissue-specific prote
195 synergistically reduced spontaneous type 1 T-helper cell responses to autoantigens, ABT-induced IL-4
196 a murine skin infection model, we compared T helper cell responses to yeast and filamentous C. albica
197 (H)2 cell and, especially, IL-17-producing T helper cell responses, and promoting memory T cell diffe
198 interferons, normalized TH1 and follicular T helper cell responses, improved TH17 differentiation, cu
202 that Env engagement of the CD4 receptor on T-helper cells results in anergic effects on T-cell recrui
203 tial B-cell clonal composition, T-follicular helper cell signaling, increased rounds of productive so
205 CV-specific CD4+ T cells with a follicular T helper cell signature that is maintained after therapy-i
208 Ps distinctly enriched in the enhancers of T helper cell subpopulations, and demonstrated relevant ce
209 ning algorithms, we identified an expanded T helper cell subset in patients with MS, characterized by
210 that a new interleukin (IL)-13-expressing T helper cell subset specifically promotes high-affinity I
211 omoting disease) and a specific T follicular helper cell subset that contributes to IgG4 isotype swit
214 Interleukin-22 is produced by certain T helper cells subsets (Th17, Th22) and at lower levels by
216 of this effector program become T follicular helper cells, supporting development of B cells expressi
218 d at high levels as a result of T follicular helper cell (TFH) and B cell interactions in germinal ce
219 exhibiting significantly higher follicular T helper cell (Tfh) and germinal center B cell frequencies
221 Germinal centres (GCs) are T follicular helper cell (Tfh)-dependent structures that form in resp
222 eady state interactions between T follicular helper cells (TfH) and B cells to limit mucosal IgA resp
226 lls to give rise to specialized T follicular helper cells (TFH) critical to initiating appropriate Ab
229 nd other lymphomas derived from follicular T-helper cells (TFH) represent a large proportion of perip
230 inin (HA) by promoting a potent T follicular helper cells (TFH) response, which directly controls the
231 ve follicles, B-cells encounter T-follicular helper cells (Tfh) that produce interleukin (IL)-21, IL-
232 d data suggest that a subset of T follicular helper cells (TFH) within germinal centers (GC) is highl
238 of less T-central-memory cells, T-follicular-helper cells, TGF-beta response, and CD4( +) T memory re
239 pression with cyclosporin after SCT limits T-helper cell (Th) 1 differentiation and interferon-gamma
240 regulatory cells (Treg cells) and effector T helper cells (Th cells), and recently identified innate
241 ers have described miR-155 upregulation in T helper cells (Th) during the development of experimental
242 SIDS increased CNS antigen-specific Type1 T helper cell (Th1) responses in the brains of 2D2 mice 14
243 cytokines to induce IL-17-producing CD4(+) T helper cells (TH17); yet their signalling network remain
245 ant mediator for the development of type 2 T-helper cell (Th2)-driven inflammatory disorders and has
247 CD4(+) (Th9) cells are a subset of CD4(+) T-helper cells that are endowed with powerful antitumor ca
248 they affect adaptive immune cells such as T helper cells that express IL-17a (T(H)17 cells) or regul
249 ignature associated with CD4(+) T follicular helper cells that is associated with longer progression-
250 differentiation of T cells into Th1 and Th2 helper cells that mediate cell-based and humoral immune
251 helper (Tfh) cells are a subset of CD4(+) T helper cells that migrate into germinal centers and prom
253 tor function of CXCR5(+)PD-1(+) T follicular helper cells, thereby controlling germinal center format
254 fects tumor surveillance by depleting CD4+ T helper cells through lipotoxic mechanisms associated wit
255 cific mechanisms are activated in tolerant T helper cells to directly repress expression of effector
256 he abilities of peripheral CXCR5(+) CD4(+) T helper cells to induce antibody secretion by autologous
258 Th17 cytokines or RORgammat, but diverted T helper cell trafficking to the gut, which improved EAE o
259 -gamma transcripts and the number of CD4 + T-helper cells transcribing this gene were elevated (P < 0
261 upon heterologous challenge, particularly T helper cell type 1 polarizing and typically monocyte-der
262 n and mucin domain 3, which down-regulates T-helper cell type 1 proinflammatory responses and is asso
264 were hyperkeratosis, hypergranulosis, mild T helper cell type 1-dominant lymphocytic inflammation, pl
265 that leads to the development of a chronic T helper cell type 1-polarized systemic immune response ac
266 f T(H)1, T helper cell type 2 (T(H)2), and T helper cell type 17 (T(H)17), and of follicular-helper T
267 We test our methods in the context of T Helper Cell Type 17 (Th17) differentiation, generating n
268 enriched for TLR (Toll-like receptor) and T-helper cell type 17 (Th17) signaling and endoplasmic ret
269 nd anti-inflammatory transcripts of T(H)1, T helper cell type 2 (T(H)2), and T helper cell type 17 (T
272 strain failed to induce the nonprotective T helper cell type 2 (Th2) responses characteristic of wil
275 F [hepatocyte growth factor]) coupled with T-helper cell type 2 and natural killer cell signaling in
277 ubtypes associated with high expression of T-helper cell type 2 cytokines and lack of corticosteroid
279 to host defense as components of adaptive T helper cell type 2 immune responses to helminths, ticks,
281 the most from specific agents that target T-helper cell type 2-mediated inflammation and/or corticos
282 ith a high dose of T. muris that induces a T helper cell type 2-polarized immune response did not aff
283 pment of anaphylaxis or heightened recall, T-helper cell type 2-skewed responses to postnatal encount
284 gramming driving their conversion from one T helper cell type to another, a process known as transdif
285 a leads to increased colonic expression of T helper cell type-2 cytokines and IL-17, associated with
286 nt to herpes SK with marked suppression of T helper cells type 1 and 17 responses both in the ocular
287 cells in vivo, limits the accumulation of T helper cells type 1, and reduces the development of athe
290 expression, and HIF promoted glycolysis in T helper cells via TCR or cytokine stimulation, as well as
292 iated with germinal centers and T follicular helper cells were examined using immunohistochemistry an
297 mory B cells and a reduction in T follicular helper cells with a phenotype suggesting recent GC activ